High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease.

"CONFLICTS OF INTEREST Roselie Achten has nothing to disclose. Judith Thijs is a speaker for Sanofi Genzyme and LEO Pharma. Marlot van der Wal has nothing to disclose. Chantal van Luijk is a speaker for Sanofi Genzyme and Santen. Matthijs van Luin has nothing to disclose. Mohsin el Amrani has nothing to disclose. Edward Knol is a speaker and advisory board member for Sanofi Genzyme. Eveline Delemarre has nothing to disclose. Constance den Hartog Jager has nothing to disclose. Marlies de Graaf is a consultant, advisory board member, and/or speaker for AbbVie, Eli Lilly, Leo Pharma, Novartis, Pfizer, Regeneron, and Sanofi‐Genzyme. Daphne Bakker is a speaker for Sanofi Genzyme and LEO Pharma. Joke de Boer has nothing to disclose. Femke van Wijk is a speaker and/or consultant for Janssen, Johnson & Johnson, and Takeda. Marjolein de Bruin‐Weller is a consultant, advisory board member, and/or speaker for AbbVie, Almirall, Aslan, Arena, Eli Lilly, Galderma, Janssen, Leo Pharma, Pfizer, Regeneron, and Sanofi‐Genzyme."

"This investigator initiated study was sponsored by Sanofi Genzyme. The sponsor was not involved in the analyses, interpretation of the data, and preparation of the manuscript."